Dicerna is headquartered in Lexington, Massachusetts.
Dicerna disclosed revenue of 164M USD for 2020 and 24M USD for 2019.
Dicerna has 302 employees.
Dicerna is a life science company.
Dicerna was founded in 2006.
75 Hayden Avenue,
Lexington, Massachusetts
02421
United States,
(617) 621-8097
www.dicerna.com
Dicerna is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to silence selectively genes that cause or contribute to disease. Using proprietary RNAi technologies, GalXC and GalXC-Plus, Dicerna is committed to developing RNAi-based therapies with the potential to treat both rare and more prevalent diseases. Dicerna was founded in 2006 and is based in Lexington, Massachusetts.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.2/yr) | # | - | 1 | - | - | - | - | 1 |
| vol | $240M | $240M | ||||||
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
J. Wood Capital Advisors |
1 |
| Legal | Deals |
|---|---|
|
Latham & Watkins |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
